My asthma attacks don't subside with Aerolin — what should I do?
When symptoms or doubts arise involving My asthma attacks don't go away with Aerolin.Distinguishing between scientifically validated information and palliative care makes all the difference in the evolution of respiratory, skin, and systemic health. This page aims to deepen understanding of... "My asthma attacks don't go away with Aerolin — What should I do?", providing clear context on how the immune system reacts, which signs require medical attention, and how to structure individualized and effective care.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
What to do when asthma attacks don't subside with Aerolin?
One of the biggest concerns in the clinical management of asthma is the persistence of symptoms even after the use of rescue medications, such as Aerolin (salbutamol). When a patient reports that their attacks do not subside with this medication, the first point to be evaluated is whether the condition is receiving adequate long-term control treatment, and not just palliative management of acute attacks.
If the patient uses a short-acting bronchodilator in isolation and continuously, without the support of inhaled anti-inflammatory drugs (such as corticosteroids) prescribed for daily control, two important phenomena may occur:
- Tachyphylaxis: This refers to the decrease in the body's response to the medication. Repeated and excessive use of beta-agonists causes cellular receptors to undergo a downregulation process (downregulation), reducing its quantity. Over time, the body begins to require higher doses to achieve the same effect, until the medication significantly loses its effectiveness.
- Bronchial remodeling: The lack of adequate anti-inflammatory treatment keeps lung tissue in a state of chronic inflammation. Over time, this persistent inflammation causes structural changes in the airways, where healthy bronchial tissue is replaced by scar tissue. This generates not only obstruction but also a permanent pulmonary restriction, further hindering breathing.
Maintenance treatment for asthma often involves the combined use of long-acting bronchodilators, which have a suitable safety profile for prolonged use under medical supervision. The goal of specialized monitoring is to gradually reduce these medications as clinical improvement and results from pulmonary function tests, such as spirometry, occur, allowing the patient to use short-acting bronchodilators only sporadically and strictly in cases of exacerbation.
Therefore, if you notice that your rescue medication is no longer having the same effect as before, it is essential to reassess your treatment strategy with a specialist physician. The Brazil Without Allergies Project emphasizes that this content is for educational and informational purposes only and does not, under any circumstances, replace consultation, diagnosis, and individualized prescription performed by a qualified physician.
Development in Evidence-Based Medicine: Bronchial Inflammation Control and Lung Function (GINA)
According to global guidelines of Global Initiative for Asthma (GINA), a bronchial asthma It is a chronic inflammatory disease of the airways characterized by bronchial hyperreactivity and variable obstruction to expiratory airflow, objectively documented by Spirometry (pulmonary function test with bronchodilator test)The fundamental therapeutic pillar consists of the continuous control of eosinophilic/Th2 inflammation of the bronchial mucosa through... inhaled corticosteroids (alone or in combination with long-acting beta-2 agonist bronchodilators — LABA, such as formoterol or salmeterol), using proper inhalation technique or a valved spacer. The isolated and repetitive use of short-acting bronchodilators (such as salbutamol or fenoterol) without inhaled anti-inflammatory coverage is associated with a higher risk of severe exacerbations and bronchial remodeling.
💎 Diamond Plan — Well-controlled asthma shouldn't require frequent trips to the emergency room. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription exclusively from the attending physician and must be administered under direct medical supervision.
Control of Bronchial Inflammation, Lung Function, and Prevention of Remodeling
Lower Airway Hyperreactivity and the Role of Inhalation Therapy
Bronchial asthma and allergic bronchitis are chronic inflammatory diseases of the lower airways, characterized by bronchial hyperreactivity, mucosal edema, mucus hypersecretion, and variable obstruction to expiratory airflow. When eosinophilic or allergic inflammation (type 2) remains uncontrolled over the years—or when the patient uses only short-term bronchodilators without treating the underlying inflammation—thickening of the basement membrane and hypertrophy of the bronchial smooth muscle occur, a process known as bronchial remodeling.
Inhalation Technique, Environmental Control and Respiratory Immunotherapy
The integration between environmental control of household dust, adherence to the prescribed preventive plan, and implementation of allergy test allows you to customize the asthma treatmentIn the presence of proven IgE sensitization, the asthma vaccine It acts on the immunological cause of respiratory hyper-reactivity, while cases of severe refractory asthma now have access to highly precise immunobiological drugs.
Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization
In eczematous dermatitis and cases of chronic pruritus, differentiating constitutional atopy from allergic contact dermatitis (a type IV delayed hypersensitivity reaction mediated by T lymphocytes sensitized to metals, cosmetic preservatives, fragrances, resins, or rubber) is essential. Repeated exposure to the sensitizing agent maintains active skin inflammation even with the use of anti-inflammatory ointments, requiring precise identification of the triggering factor.
Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication
Drug hypersensitivity reactions encompass distinct immunological and pharmacological mechanisms: from immediate reactions (up to one to six hours after dosing, manifested by urticaria, labial or palpebral angioedema, bronchospasm, and anaphylaxis, common with COX-1 inhibitor analgesics and beta-lactams) to delayed drug eruptions mediated by T cells, such as maculopapular rashes and DRESS syndrome — a systemic condition that arises weeks after the start of anticonvulsants, sulfones, or allopurinol, presenting with fever, lymphadenomegaly, eosinophilia, and the need for immediate discontinuation under hospital supervision.
Clinical Safety Criteria and Warning Signs in Allergology
Early recognition of warning signs requiring priority medical reassessment is part of the health education of every patient and their family. Symptoms such as progressive dyspnea (difficulty breathing or speaking in complete sentences), refractory wheezing, sudden edema of the lips, tongue, or glottis, dizziness due to a drop in blood pressure, persistent fever associated with skin lesions or mucous membrane involvement require immediate emergency care, followed by a structured allergy investigation to prevent future recurrences.
Impact on Quality of Life, Sleep, and Systemic Well-being
Beyond the direct physical manifestations, uncontrolled conditions linked to asthma attacks that don't subside with Aerolin profoundly interfere with restorative sleep patterns, concentration at school and work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, reinforces the immune inflammatory response. Therefore, instituting a comprehensive approach to clinical and environmental rehabilitation restores daily autonomy and overall well-being to the individual.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan It was designed for patients throughout Brazil who face the high cost of allergy vaccines and the difficulties of traveling, offering specialized follow-up through telemedicine and easy access to immunotherapy treatment. Well-controlled asthma should not depend on frequent trips to the emergency room.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription exclusively from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
In summary, the appropriate approach to My asthma attacks don't go away with Aerolin. It requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoiding self-medication and investigating the root cause of symptoms—relying on specialized resources and reliable guidance such as specialized allergy and immunology care when clinically relevant—is the safest way to control flare-ups, prevent complications, and ensure sustainable quality of life.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




